- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Early Manifest Huntington Disease in Canada
Total 127 results
-
Novartis PharmaceuticalsCompletedEarly Manifest Huntington DiseaseCanada, Germany, France, Spain, Hungary
-
Neurocrine BiosciencesEnrolling by invitation
-
Hoffmann-La RocheCompletedHuntingtons DiseaseUnited States, United Kingdom, Australia, Canada, Japan, Poland, Netherlands, Germany, Russian Federation, France, Spain, Argentina, New Zealand, Austria, Denmark, Italy, Switzerland, Chile
-
GAAD Medical Research Institute Inc.UnknownHuntington DiseaseCanada
-
University of British ColumbiaHuntington Study Group; Huntington Society of CanadaCompletedHuntington DiseaseCanada
-
York UniversityNorth York General HospitalCompleted
-
Neurocrine BiosciencesHuntington Study GroupActive, not recruitingChorea, HuntingtonUnited States, Canada
-
Neurocrine BiosciencesHuntington Study GroupCompletedChorea, HuntingtonUnited States, Canada
-
CHDI Foundation, Inc.The University of Texas Health Science Center, Houston; Dr. Glenn T. Stebbins... and other collaboratorsCompleted
-
University of ManitobaChildren's Hospital Research Institute of ManitobaCompletedEarly Childhood CariesCanada
-
Auspex Pharmaceuticals, Inc.CompletedChorea Associated With Huntington DiseaseUnited States, Australia, Canada
-
CHDI Foundation, Inc.Dr. Glenn T. Stebbins (Rush University Medical Center ); Dr. Nancy LaPelleCompleted
-
Ionis Pharmaceuticals, Inc.CompletedHuntington's DiseaseCanada, United Kingdom, Germany
-
Hoffmann-La RocheCompleted
-
Sunnybrook Health Sciences CentreUniversity Health Network, Toronto; University of TorontoCompleted
-
Merit CudkowiczFDA Office of Orphan Products DevelopmentCompleted
-
CHDI Foundation, Inc.Medpace, Inc.Active, not recruitingNatural History Study in Huntington Disease Gene Expansion Carriers (HDGECs) - SHIELD HD (SHIELD HD)Huntington DiseaseUnited States, Canada, France, Germany, United Kingdom
-
Wave Life Sciences Ltd.TerminatedHuntington DiseaseDenmark, Australia, Canada, France, United Kingdom, Germany, Poland
-
PTC TherapeuticsRecruitingHuntington DiseaseAustralia, France, Germany, Netherlands, United Kingdom, Spain, Austria, Canada, Italy, New Zealand
-
Wave Life Sciences Ltd.RecruitingHuntington DiseaseCanada, Spain, Australia, Denmark, Netherlands, Poland, United Kingdom, France, Germany, Italy
-
Hoffmann-La RocheCompletedHuntington's DiseaseUnited Kingdom, United States, Germany, Canada
-
Sage TherapeuticsRecruitingHuntington DiseaseUnited States, Canada
-
Sunnybrook Health Sciences CentreCanadian Arthritis NetworkCompletedChronic Disease | Early Inflammatory ArthritisCanada
-
University of TorontoUniversity of ManitobaUnknownDental Caries | Early Childhood CariesCanada
-
Wave Life Sciences Ltd.TerminatedHuntington's DiseaseUnited States, Denmark, Canada, Australia, United Kingdom, France, Germany, Poland
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedHuntington DiseaseUnited States, Canada
-
Wave Life Sciences Ltd.TerminatedHuntington DiseaseDenmark, Australia, Canada, France, United Kingdom, Germany, Poland
-
Sunnybrook Health Sciences CentreCanadian Arthritis NetworkCompletedChronic Disease | Early Inflammatory ArthritisCanada
-
Wave Life Sciences Ltd.TerminatedHuntington's DiseaseDenmark, Canada, Australia, United Kingdom, France, Germany, Poland
-
CHDI Foundation, Inc.Monash UniversityCompletedHuntington's DiseaseUnited States, Australia, United Kingdom, Canada
-
University College, LondonCHDI Foundation, Inc.RecruitingHuntington's DiseaseUnited States, United Kingdom, Canada, Germany, Italy, Spain, New Zealand, Poland
-
Vaccinex Inc.Huntington Study GroupCompletedHuntington's DiseaseUnited States, Canada
-
PfizerTerminatedHuntington's DiseaseUnited States, Germany, Poland, United Kingdom, Canada
-
Amarin Neuroscience LtdHuntington Study GroupCompletedHuntington DiseaseUnited States, Canada
-
University of AlbertaJohnson & JohnsonCompletedOperable Early Stage NSCLC by the VATS ApproachCanada
-
Huntington Study GroupNational Institute of Neurological Disorders and Stroke (NINDS); National Human...UnknownHuntington DiseaseUnited States, Canada
-
PTC TherapeuticsRecruitingA Study to Evaluate the Safety and Efficacy of PTC518 in Participants With Huntington's Disease (HD)Huntington DiseaseUnited States, Austria, Spain, United Kingdom, Australia, France, Germany, Netherlands, Italy, New Zealand, Canada
-
Teva Branded Pharmaceutical Products R&D, Inc.Completed
-
Massachusetts General HospitalNational Institute of Neurological Disorders and Stroke (NINDS); University...TerminatedHuntington's DiseaseUnited States, Australia, Canada
-
Ottawa Hospital Research InstituteActive, not recruitingEarly-stage Breast CancerCanada
-
Juravinski Cancer CenterCompletedEarly Stage Breast CancerCanada
-
PfizerCompletedHuntington's DiseaseUnited States, Germany, United Kingdom, Canada, Poland
-
PrileniaActive, not recruitingHuntington DiseaseUnited States, Austria, Canada, Czechia, France, Germany, Italy, Netherlands, Poland, Spain, United Kingdom
-
InSightecActive, not recruitingParkinson's Disease | Movement Disorders | Tardive Dyskinesia | Dystonia | Essential Tremor | Huntington's Disease | Wilson's Disease | Holmes Tremor | Orofacial DyskinesiasCanada
-
Ottawa Hospital Research InstituteCompletedEarly-stage Breast CancerCanada
-
Sage TherapeuticsRecruitingHuntington's DiseaseUnited States, Australia, Canada, United Kingdom
-
PrileniaTerminatedHuntington's DiseaseUnited States, Australia, Austria, Canada, France, Germany, Italy, Netherlands, Poland, Russian Federation, United Kingdom
-
Hoffmann-La RocheCompletedHuntington DiseaseUnited States, Canada, Netherlands, Germany, Spain, United Kingdom, Austria, Italy
-
Massachusetts General HospitalNational Center for Complementary and Integrative Health (NCCIH); University...TerminatedHuntington's DiseaseUnited States, Canada, New Zealand, Australia
-
HP Therapeutics FoundationHuntington Study GroupUnknownHuntington DiseaseUnited States, Canada, Australia